Non Hepatosplenic Extramedullary Manifestations of Chronic Myelomonocytic Leukemia: Clinical, Molecular and Prognostic Correlates

Benzer Materyaller

• Nucleophosmin 1 (NPM1) Mutations in Chronic Myelomonocytic Leukemia and Their Prognostic Relevance
  Yazar:: Vallapureddy, Rangit, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental
  Yazar:: Patnaik, Mrinal M., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
  Yazar:: Lasho, Terra L., ve diğerleri
  Baskı/Yayın Bilgisi: (2018)
• A prospective evaluation of vitamin B1 (thiamine) level in myeloproliferative neoplasms: clinical correlations and impact of JAK2 inhibitor therapy
  Yazar:: Gangat, Naseema, ve diğerleri
  Baskı/Yayın Bilgisi: (2019)
• Splenectomy in patients with chronic myelomonocytic leukemia: Indications, histopathological findings and clinical outcomes in a single institutional series of 39 patients
  Yazar:: Pophali, Prateek, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)